Create SD Holdings Co Ltd

Create SD Holdings maintains a strong liquidity position, with a current ratio of 1.32 and JPY 37.75 billion in cash and equivalents, despite a negative free cash flow of JPY 866 million. The company has no long-term debt, resulting in a debt-to-equity ratio of 0.0, which is significantly lower than the industry median for drug retailers. Profitability metrics show a return on equity (ROE) of 10.99% and a return on assets (ROA) of 6.63%, both of which are above the industry median for drug retailers. The company's operating margin is 4.64% (JPY 21.2 billion operating income on JPY 457.09 billion revenue), and its net margin is 3.43% (JPY 15.69 billion net income on JPY 457.09 billion revenue). Geographically, the company is concentrated in Japan, with no disclosed international operations. Segment-wise, the company operates as a single business unit, with no material revenue diversification across product lines or geographic regions. The company's revenue growth has been stable, with a revenue of JPY 457.09 billion in the latest period. Looking ahead, the company is expected to maintain its current trajectory, with no significant changes in revenue or operating income projected for the next fiscal year. Risk factors for the company are minimal, with no immediate liquidity or dilution concerns. The company has no long-term debt and a low dilution risk, with shares outstanding remaining unchanged between basic and diluted shares. Recent financial filings and transcripts show no material changes in the company's operations or strategy. The company continues to focus on maintaining its market position in the drug retailing sector in Japan.